What is the Definition of being Fully Vaccinated? Should the Three-dose Vaccination with the mRNA Vaccines be the New Standard
Main Article Content
Keywords
COVID-19, SARS-CoV-2, Omicron, 5.1.1.529 Variant, CDC, FDA, Pfizer/BioNTech Vaccine, Moderna Vaccine, Jansen Vaccine
Abstract
N/A
References
1. WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int/ (Accessed on December 09, 2021; 15:40 hrs)
2. COVID Data Tracker. Centers for Disease Control and Prevention. CDC Data Tracker. (Accessed on December 09, 2021; 15:50 hrs)
3. Chemaitelly H, Tang P, Hasan MR, et. al. Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar. N. Engl J Med 2021; 385:e83. DOI: 10.1056/NEJMoa2114114
4. Levin EG, Lustig Y, Cohen C, et. al. Waning Immune Humoral Responses to BNT162b2 Covid-19 Vaccine Over 6 Months. N. Eng J Med 2021; 385:e84
DOI: 10.1056/NEJMoa2114583
5. Bar-On YM, Goldberg Y, Mandel M, et.al. Protection of BNT162b2 Vaccine Booster Against Covid-19 in Israel. N Engl J Med 2021; 385:1393-1400
DOI: 10.1056/NEJMoa2114255
6. Barda N, Dagan N, Cohen C, et.al. Effectiveness of a Third Dose of the BNT162b2 mRNA COVID-19 Vaccine for Preventing Severe Outcomes in Israel: An Observational Study. Lancet 2021; 398: 2093-100. DOI: 10.1016/S0140-6736(21)02249-2
7. Coronavirus (COVID-19) Update: FDA Authorizes Additional Vaccine Dose for Certain Immunocompromised Individuals. Aug 12, 2021. FDA News Release.
8. CDC Expands Eligibility for COVID-19 Booster Shots to All Adults. Nov 19, 2021. CDC News Release.
9. Coronavirus (COVID-19) Update: FDA Expands Eligibility for Pfizer-BioNTech COVID-19 Booster Dose to 16 and 17 Year Olds. Dec 09, 2021. FDA News Release.
10. Cheng, M. What is this New COVID Variant in South Africa. November 26, 2021. Associated Press. https://www.aol.com/explainer-covid-variant-south-africa-111307372-142856393.html
11. Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern. World Health Organization. November 26, 2021. WHO Statement
12. Statement from President Joe Biden on the Omicron COVID-19 Variant. The White House. November 26, 2021. Whitehouse Statement
13. Cele S, Jackson L, Khan K, et.al. SARS-CoV-2 Omicron has Extensive but Incomplete Escape of Pfizer BNT 162b2 Elicited Neutralization and Requires ACE2 for Infection. medRxiv 2021.12.08.21267417; DOI: 10.1101/2021.12.08.2126741715
14. Chen J, Wang R, Gilby NB, Wei GW. Omicron (B.1.1.529): Infectivity, vaccine breakthrough, and antibody resistance. ArXiv [Preprint]. 2021 Dec 1:arXiv:2112.01318v1. PMID: 34873578; PMCID: PMC8647651.
15. Pfizer and BioNTech Provide Update on Omicron Variant. Dec 08, 2021. Pfizer/BioNTech News Release
2. COVID Data Tracker. Centers for Disease Control and Prevention. CDC Data Tracker. (Accessed on December 09, 2021; 15:50 hrs)
3. Chemaitelly H, Tang P, Hasan MR, et. al. Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar. N. Engl J Med 2021; 385:e83. DOI: 10.1056/NEJMoa2114114
4. Levin EG, Lustig Y, Cohen C, et. al. Waning Immune Humoral Responses to BNT162b2 Covid-19 Vaccine Over 6 Months. N. Eng J Med 2021; 385:e84
DOI: 10.1056/NEJMoa2114583
5. Bar-On YM, Goldberg Y, Mandel M, et.al. Protection of BNT162b2 Vaccine Booster Against Covid-19 in Israel. N Engl J Med 2021; 385:1393-1400
DOI: 10.1056/NEJMoa2114255
6. Barda N, Dagan N, Cohen C, et.al. Effectiveness of a Third Dose of the BNT162b2 mRNA COVID-19 Vaccine for Preventing Severe Outcomes in Israel: An Observational Study. Lancet 2021; 398: 2093-100. DOI: 10.1016/S0140-6736(21)02249-2
7. Coronavirus (COVID-19) Update: FDA Authorizes Additional Vaccine Dose for Certain Immunocompromised Individuals. Aug 12, 2021. FDA News Release.
8. CDC Expands Eligibility for COVID-19 Booster Shots to All Adults. Nov 19, 2021. CDC News Release.
9. Coronavirus (COVID-19) Update: FDA Expands Eligibility for Pfizer-BioNTech COVID-19 Booster Dose to 16 and 17 Year Olds. Dec 09, 2021. FDA News Release.
10. Cheng, M. What is this New COVID Variant in South Africa. November 26, 2021. Associated Press. https://www.aol.com/explainer-covid-variant-south-africa-111307372-142856393.html
11. Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern. World Health Organization. November 26, 2021. WHO Statement
12. Statement from President Joe Biden on the Omicron COVID-19 Variant. The White House. November 26, 2021. Whitehouse Statement
13. Cele S, Jackson L, Khan K, et.al. SARS-CoV-2 Omicron has Extensive but Incomplete Escape of Pfizer BNT 162b2 Elicited Neutralization and Requires ACE2 for Infection. medRxiv 2021.12.08.21267417; DOI: 10.1101/2021.12.08.2126741715
14. Chen J, Wang R, Gilby NB, Wei GW. Omicron (B.1.1.529): Infectivity, vaccine breakthrough, and antibody resistance. ArXiv [Preprint]. 2021 Dec 1:arXiv:2112.01318v1. PMID: 34873578; PMCID: PMC8647651.
15. Pfizer and BioNTech Provide Update on Omicron Variant. Dec 08, 2021. Pfizer/BioNTech News Release